Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsReceivables - NetShares Outstanding
Ratios

Guided Therapeutics (GTHP) Accumulated Depreciation & Amortization (2019 - 2020)

Historic Accumulated Depreciation & Amortization for Guided Therapeutics (GTHP) over the last 2 years, with Q4 2020 value amounting to $1.7 million.

  • Guided Therapeutics' Accumulated Depreciation & Amortization fell 2703.72% to $1.7 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.7 million, marking a year-over-year decrease of 2703.72%. This contributed to the annual value of $1.7 million for FY2020, which is 2703.72% down from last year.
  • As of Q4 2020, Guided Therapeutics' Accumulated Depreciation & Amortization stood at $1.7 million, which was down 2703.72% from $2.4 million recorded in Q4 2019.
  • Guided Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $2.4 million during Q4 2019, with a 5-year trough of $1.7 million in Q4 2020.